Indication
Meningococcal Disease
2 clinical trials
2 products
Clinical trial
A Phase 3, Multi-center, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Children, Adolescents and Adults in RussiaStatus: Completed, Estimated PCD: 2013-03-01
Product
MenACWY-CRMClinical trial
Immunisation for Adolescents Against Serious Communicable DiseasesStatus: Recruiting, Estimated PCD: 2024-12-31
Product
4CMenB Vaccine